Cargando…
Assessment of Candida auris Response to Antifungal Drugs Using Time–Kill Assays and an Animal Model
BACKGROUND: Candida auris is an emerging nosocomial pathogen that is resistant to Fluconazole and variably susceptible to other systemic drug classes. Treatment with echinocandins has been recommended based on MICs in the susceptible range, but supporting in vivo data is lacking. METHODS: We tested...
Autores principales: | Ben-Ami, Ronen, Ashkenazi, Liat, Berman, Judith, Korolker, Nuphar, Novikov, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631757/ http://dx.doi.org/10.1093/ofid/ofx163.003 |
Ejemplares similares
-
Candida auris Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS
por: Vatanshenassan, Mansoureh, et al.
Publicado: (2019) -
Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel
por: Ben-Ami, Ronen, et al.
Publicado: (2017) -
Replicative Aging in Candida auris Has an Effect on Antifungal Resistance
por: Fries, Bettina C, et al.
Publicado: (2017) -
Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017
por: Belkin, Ana, et al.
Publicado: (2018) -
Identification and Antifungal Drug Susceptibility Pattern of Candida auris in India
por: Deshkar, Smita, et al.
Publicado: (2022)